An increasing number of studies have used high (3T) and ultra-high (7T) field magnetic resonance imaging (MRI) to better visualize and characterize multiple sclerosis (MS)-related pathology. These studies were mostly aimed at using an increase in signal-to-noise ratio (SNR) to enhance spatial resolution and image contrast. With white matter lesions already well visible at standard field strength, this increase in image contrast proved especially fruitful for the detection of cortical gray matter lesions. Compared to a double inversion recovery (DIR) sequence at 1.5T, DIR at 3T provided a 192% increase in (intra)cortical lesion detection. 1 Even higher field strengths brought further improvements. A recent study comparing five different MRI sequences at two different field strengths (3T and 7T) showed that overall 7T MRI detected 59% more cortical lesions than 3T MRI. 2 Nevertheless, when studying the sequences separately, only two out of five sequences (fluid-attenuated inversion recovery (FLAIR) and T2*) really benefitted from an increase in field strength above 3T.
Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology -NO Laura Jonkman
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Although cortical lesions are correlated with cognitive impairment, 3 it can be questioned whether increasing lesion detection should really be the next step in unraveling MS pathophysiology. Previous research has shown that the number of MRI-visible cortical lesions increases with the total number of lesions confirmed histopathologically (i.e. including the invisible ones). 4 This indicates that we already have a fair reflection of the cortical lesion burden, even at 3T when 100% detection rate is not guaranteed. Therefore, it seems futile to increase lesion detection rates at increasingly higher field strengths. We should perhaps focus on other research directions instead.
There is an increasing interest in using (functional and) structural network dysfunction as a new biomarker for a patient's clinico-cognitive status. In MS, diffusion tensor imaging (DTI) has been used to assess microarchitectural white matter disorganization. It has been shown that in lesions, compared to normal-appearing white matter (NAWM), mean diffusivity (MD) increases, while fractional anisotropy (FA) decreases. These changes reflect axonal and myelin disintegration, as observed in histopathological studies on MS lesions. It has even been shown that the biggest change in diffusion (least restrictive) is observed in so-called black holes, areas hypointense on T1 weighted images, reflecting chronic destruction of tissue. 5 When looking at a whole-brain network level, studies show that network efficiency loss was proportional to the total white matter load. 6 Moreover, several DTI studies in MS have found correlations between DTI (network) metrics and physical and cognitive disability.
In the clinical setting, it is unclear why some patients convert to a status of "cognitive impairment," while other very similar patients do not. An MS disease progression hypothesis has been proposed: in early MS, it is thought that functional changes in the brain (i.e. functional reorganization) can circumvent structural damage, thereby limiting functional decline (phase 1-2). Subsequently, structural damage and atrophy rates suddenly peak and clinico-cognitive decline increases. It is believed that a network collapse may develop in this phase, limiting functional reorganization (phase 3). Interestingly, some patients remain in phase 1-2 much longer than other patients, but it is still unknown why. The interplay between pathophysiology and networks remains to be elucidated; which pathological changes are related to specific structural and functional network changes?
With more in vivo research relating clinico-cognitive status to (structural) network outcome measures, the post-mortem (in situ) setting can be a very beneficial next step to elucidate the above mentioned question. It doesn't even require ultra-high-field MRI. In the ideal situation, clinico-cognitive status of the deceased patient is known, and an in situ post-mortem T1-w and DTI sequence at 3T MRI are acquired. These are sufficient to characterize DTI metrics and visualize structural networks, atrophy, and the regions involved. Subsequent histopathological analysis could in turn L Jonkman give a better understanding of the pathological processes that underlie differences in DTI metrics, structural networks, and regional atrophy that correlate to clinico-cognitive status.
Some support for the above-mentioned associations between pathological processes and network connectivity have already been shown in animal models. In rats with traumatic brain injury, increased white matter connectivity relates to tissue astrocyte reactivity. 7 In a rodent model of Alzheimer's disease, brain network activity links interneuron dysfunction to cognitive deficits. 8 In experimental autoimmune encephalomyelitis (EAE) mice, a pro-excitatory shift in the balance of excitation and inhibition led to large-scale (functional and) structural plasticity. 9 These studies provide some evidence suggesting that network topology is interposed between pathophysiology and behavior. To study this in human tissue, ultra-high-field MRI is not required, but a regular MRI scan, high-quality histology, and a (confocal) microscope are.
Aside from 3T MRI being closer to the clinical setting, there are also other issues with 7T MRI that need to be taken into account; issues related to safety, patient comfort, and higher costs. Additionally, there are several technical difficulties; T2 and T2* relaxation times shorten, maintaining a homogeneous radiofrequency (RF) (B 1 ) field is challenging, and increased power deposition results in restrictions due to the specific absorption rate (SAR). 10 With limited acquisition times, obtaining high-quality 7T MRI (especially diffusion MRI) remains challenging.
In summary, to understand MS pathophysiology, it is not necessary to move to 7T and beyond. 7T MRI has some technical limitations at clinically useful acquisition times, not to mention the higher costs than 3T MRI. In terms of research questions, there are far more interesting questions regarding pathophysiology of MS than visualizing cortical gray matter lesions with increasing field strengths. One clinically relevant area of interest is the pathophysiology of clinico-cognitive status through structural network analysis, which could be investigated using "just" 3T MRI.
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